These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11727327)

  • 1. Standardized electroretinography in primates: a non-invasive preclinical tool for predicting ocular side effects in humans.
    Bee WH
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):81-91. PubMed ID: 11727327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal and ocular toxicity in ocular application of drugs and chemicals--part I: animal models and toxicity assays.
    Penha FM; Rodrigues EB; Maia M; Dib E; Fiod Costa E; Furlani BA; Nunes Moraes Filho M; Dreyfuss JL; Bottós J; Farah ME
    Ophthalmic Res; 2010; 44(2):82-104. PubMed ID: 20484950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal electrophysiology for toxicology studies: applications and limits of ERG in animals and ex vivo recordings.
    Rosolen SG; Kolomiets B; Varela O; Picaud S
    Exp Toxicol Pathol; 2008 Jun; 60(1):17-32. PubMed ID: 18294830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do preclinical testing strategies help predict human hepatotoxic potentials?
    Peters TS
    Toxicol Pathol; 2005; 33(1):146-54. PubMed ID: 15805066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic infections in non-human primates exposed to immunomodulatory biotherapeutics: considerations and case examples.
    Hutto DL
    J Immunotoxicol; 2010; 7(2):120-7. PubMed ID: 19909226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system.
    Wang C; Slikker W
    Anesth Analg; 2008 Jun; 106(6):1643-58. PubMed ID: 18499593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive power of preclinical studies in animals for the immunogenicity of recombinant therapeutic proteins in humans.
    Bugelski PJ; Treacy G
    Curr Opin Mol Ther; 2004 Feb; 6(1):10-6. PubMed ID: 15011776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory testing in non-human primates.
    Gilbert SG
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1987 Oct; 185(1-2):32-5. PubMed ID: 3124384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates.
    Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Goto Y; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
    Hum Gene Ther; 2009 Sep; 20(9):943-54. PubMed ID: 19416079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A current practice for predicting ocular toxicity of systemically delivered drugs.
    Somps CJ; Greene N; Render JA; Aleo MD; Fortner JH; Dykens JA; Phillips G
    Cutan Ocul Toxicol; 2009; 28(1):1-18. PubMed ID: 19514919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical efficacy and safety models for mAbs: the challenge of developing effective model systems.
    Dixit R; Coats S
    IDrugs; 2009 Feb; 12(2):103-8. PubMed ID: 19204884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular toxicity assessment from systemically administered xenobiotics: considerations in drug development.
    Brock WJ; Somps CJ; Torti V; Render JA; Jamison J; Rivera MI
    Int J Toxicol; 2013; 32(3):171-88. PubMed ID: 23616147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease.
    Kim H; Csaky KG; Gilger BC; Dunn JP; Lee SS; Tremblay M; de Monasterio F; Tansey G; Yuan P; Bungay PM; Lutz RJ; Robinson MR
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):655-62. PubMed ID: 15671296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical testing on insects predicts human haematotoxic potentials.
    Berger J
    Lab Anim; 2009 Oct; 43(4):328-32. PubMed ID: 19505933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of predicting drug toxicity in silico.
    Vedani A; Dobler M; Lill MA
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):195-208. PubMed ID: 16930291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive electroretinography.
    Carpi F; Tomei F
    Biomed Pharmacother; 2006 Sep; 60(8):375-9. PubMed ID: 16935463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for ocular phototoxicity.
    Roberts JE
    Int J Toxicol; 2002; 21(6):491-500. PubMed ID: 12537645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral drug studies in nonhuman primates: a valid animal model for innovative drug efficacy and pathogenesis experiments.
    Van Rompay KK
    AIDS Rev; 2005; 7(2):67-83. PubMed ID: 16092501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.